1-855-378-42281-855-378-4228
One of the out-patient rehabilitation alternatives for individuals in Robbins struggling with opioid abuse and addiction is called opioid maintenance therapy. Some clinics and doctors are certified to dispense certain meds to opioid dependent clients, many of which are opioids themselves and are habit forming. In low enough amounts the user doesn't experience high feelings but also doesn't experience intense cravings and is not in opioid withdrawal. Methadone is the first medication administered for this sole purpose, but there are alternative choices to choose from.
Methadone is an opiate and can be taken at an outpatient medical center licensed to dispense the drug, which is taken daily in liquid or pill form. The price of the drug is around under $200 per month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But different from Methadone which is only be administered in highly structured medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around $300 monthly for the generic version of the medication. There is also a type of buprenorphine that contains the ingredient naloxone, that is a med that reverses the effects of opioids. Someone consuming this version of the drug, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and costs around $450 per month. Naltrexone is an additional drug used in opioid maintenance therapy, but unlike the other medications aforementioned it's an opioid blocker and is not an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, the drug prevents a person from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 per month.
For All Alcohol and Drug Rehabilitation Programs In Robbins, Click Here.
